Mavrilimumab Biosimilar - Research Grade,ichor.bio,ICH5054

Detects human GM-CSF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Mavrilimumab.

Host

CHO Cells

Reactivity

Human

Platform ID

BAB324931987

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

Contact

Tel:
Fax:

Product Specifications

Specifications

NameMavrilimumab Biosimilar - Research Grade
Cat. No.ICH5054
Accession NumberP04141
HostCHO Cells
IsotypeHuman IgG1-Lambda2
ReactivityHuman
Concentration5mg/ml
TargetGM-CSF
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.